Koyfin Home > Directory > Health Care > Acceleron Pharma > Cash and Short-Term Investments

Acceleron Pharma Cash and Short-Term Investments Chart (XLRN)

Acceleron Pharma annual/quarterly Cash and Short-Term Investments from 2012 to 2020.
  • Acceleron Pharma Cash and Short-Term Investments for the quarter ending June 06, 2020 was $390m a -9.30% decrease of -36m year over year
  • Acceleron Pharma Cash and Short-Term Investments for the last 12 months ending June 06, 2020 was $390m a -9.30% decrease of -36m year over year
  • Acceleron Pharma Annual Cash and Short-Term Investments for 2019 was $431m a 32.47% increase of 140m from 2018
  • Acceleron Pharma Annual Cash and Short-Term Investments for 2018 was $291m a 4.84% increase of 14m from 2017
  • Acceleron Pharma Annual Cash and Short-Term Investments for 2017 was $277m a 49.61% increase of 138m from 2016
Other Balance Sheet Metrics:
  • Acceleron Pharma Total Assets for the quarter ending September 09, 2018 was $338m a -15.10% decrease of -51m year over year
  • Acceleron Pharma Other Liabilities for the quarter ending December 12, 2018 was $4m a 14.46% increase of 1m year over year
  • Acceleron Pharma Total Equity for the quarter ending September 09, 2018 was $319m a -14.45% decrease of -46m year over year
View Chart On Koyfin

Quarterly XLRN Cash and Short-Term Investments Data

06/2020$390m
03/2020$414m
12/2019$431m
09/2019$426m
06/2019$431m
03/2019$438m
12/2018$291m
09/2018$308m
06/2018$288m
03/2018$292m

Annual XLRN Cash and Short-Term Investments Data

2019$431m
2018$291m
2017$277m
2016$140m
2015$105m
2014$176m
2013$113m
2012$40m
2011$65m